Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Cilostazol Reduces Angiographic Restenosis After Endovascular Therapy for Femoropopliteal Lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol Study

(2013) Osamu Iida et al.   CIRCULATION

Dual Antiplatelet Therapy Clopidogrel with Low-dose Cilostazol Intensifies Platelet Inhibition in Patients with Ischemic Stroke

(2013) Hajime Maruyama et al.   INTERNAL MEDICINE

Cilostazol for peripheral arterial disease could reduce stroke risk?

(2013) A. Watson et al.   THROMBOSIS RESEARCH

Meta-Analysis of Randomized Controlled Trials on Effect of Cilostazol on Restenosis Rates and Outcomes After Percutaneous Coronary Intervention

(2012) Sayuri N. Friedland et al.   AMERICAN JOURNAL OF CARDIOLOGY

A Meta-Analysis of Randomized Controlled Trials Appraising the Efficacy and Safety of Cilostazol after Coronary Artery Stent Implantation

(2012) Jae-Sik Jang et al.   CARDIOLOGY

Cilostazol and Primary-PCI: Mirage or Good Alternative?

(2012) Italo Porto et al.   Current Vascular Pharmacology

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

(2012) Hani Jneid et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells

(2012) Tomoji Takigawa et al.   JOURNAL OF VASCULAR SURGERY

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary

(2011) et al.   CIRCULATION

Antiplatelet therapy in patients with ST-elevation myocardial infarction undergoing myocardial revascularisation: beyond clopidogrel

(2011) J. Wouter Jukema et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?

(2011) Manfredi Rizzo et al.   EXPERT OPINION ON PHARMACOTHERAPY

A meta-analysis of randomized trials of triple versus dual antiplatelet therapy after stent-based percutaneous coronary intervention

(2011) Hisato Takagi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI

(2011) Guido Parodi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease

(2011) Jung-Won Suh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions

(2011) Seung-Whan Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials

(2011) Umesh Tamhane et al.   EuroIntervention

Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)

(2010) Seung-Whan Lee et al.   AMERICAN HEART JOURNAL

Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up

(2010) Chul Min Ahn et al.   HEART AND VESSELS

Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes

(2010) Giuseppe Biondi-Zoccai et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

(2010) Christopher P Cannon et al.   LANCET

Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study

(2009) Yaling Han et al.   AMERICAN HEART JOURNAL

Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug–Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)

(2009) Seung-Whan Lee et al.   AMERICAN JOURNAL OF CARDIOLOGY

Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management

(2009) Michael J. Cowley et al.   CURRENT MEDICAL RESEARCH AND OPINION

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarctionThis article is one of a selection of papers published in the special issue Bridging the Gap: Where Progress in Cardiovascular and Neurophysiologic Research Meet.

(2008) Santosh K. Sanganalmath et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events — A meta-analysis

(2008) Francesco Sofi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure

(2008) Santosh K. Sanganalmath et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE